Moderna Therapeutics (NASDAQ: MRNA) recently filed a statement with regulators that outlines forward-looking statements its executives recently made in public. Specifically, during a recent interview with investment bank analysts, CEO Stephane Mancel said a COVID-19 vaccine could be available to some people this fall
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,